Quarterly ResultMay 11, 2026, 04:16 PM
Hims & Hers Q1 Revenue $608.1M, up 4%; Raises FY26 Guidance
AI Summary
Hims & Hers Health, Inc. announced first-quarter 2026 financial results, with revenue increasing 4% year-over-year to $608.1 million and subscribers growing 9% to nearly 2.6 million. Despite reporting a net loss of $92.1 million and a decrease in Adjusted EBITDA, the company raised its full-year 2026 revenue guidance to $2.8 billion to $3.0 billion and updated its Adjusted EBITDA guidance. The company highlighted a strategic pivot to branded GLP-1 products and expansion into new categories and countries.
Key Highlights
- Hims & Hers reported Q1 2026 revenue of $608.1 million, a 4% increase year-over-year.
- Subscribers grew 9% year-over-year to nearly 2.6 million.
- The company reported a net loss of $92.1 million in Q1 2026, compared to net income of $49.5 million in Q1 2025.
- Adjusted EBITDA for Q1 2026 was $44.3 million, down from $91.1 million in Q1 2025.
- Full-year 2026 revenue guidance was raised to a range of $2.8 billion to $3.0 billion.
- Full-year 2026 Adjusted EBITDA guidance was updated to a range of $275 million to $350 million.
- Gross margin decreased to 65% in Q1 2026 from 73% in Q1 2025.
- Rest of the World Revenue surged 969% year-over-year to $78.2 million.